The traders did get a bit carried away there. ok, two good mouse models, but a $50m mkt cap rise was a bit over the top at this stage. Although I'm sure there's more to come.
It just shows how the sp can move up though on a good ann.
- Forums
- ASX - By Stock
- NEU
- Ann: Validation for NNZ-2591 neurodevelopmental disorder pipeline
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.87%
!
$13.09

Ann: Validation for NNZ-2591 neurodevelopmental disorder pipeline, page-10
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.09 |
Change
0.240(1.87%) |
Mkt cap ! $1.652B |
Open | High | Low | Value | Volume |
$13.15 | $13.37 | $12.92 | $4.471M | 340.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9 | $13.09 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.10 | 225 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10 | 13.110 |
5 | 87 | 13.100 |
2 | 307 | 13.090 |
5 | 1008 | 13.080 |
4 | 1258 | 13.070 |
Price($) | Vol. | No. |
---|---|---|
13.120 | 1311 | 16 |
13.130 | 1178 | 12 |
13.140 | 1703 | 18 |
13.150 | 2138 | 14 |
13.160 | 1671 | 9 |
Last trade - 12.42pm 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
SPONSORED BY The Market Online